PLEK2 and Splenomegaly: Consistently, the thal plek2+/− mice that survived to analysis do not impact splenomegaly (Fig. 2a), exhibit borderline increased fraction of bone marrow erythroblasts (Fig. 2b), but do reveal further increased serum Epo (Fig. 2c).